Clinical Trial Update: Open Label, Multicentre Trial to Assess Safety and Efficacy of ITF2357 in Active Systemic Juvenile Idiopathic Arthritis [Phase 2]

View source ↗

Summary

Phase 2 open-label multicenter trial assessing safety and efficacy of ITF2357 in active systemic juvenile idiopathic arthritis has completed with results posted…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Systemic Juvenile Idiopathic Arthritis

Drugs mentioned

• ITF2357 (ITF2357)

Snippet

Sponsor: Italfarmaco | Conditions: Active Systemic, Onset Juvenile Idiopathic Arthritis | Phase 2 | Status: COMPLETED | Results posted: 2021-05-04